Ebola continues to spread in Africa and ignite fears with the Democratic Republic of Congo reporting its first cases over the weekend. The Congo is hundreds of miles away from the nearest affected country, but officials there say they suspect they've had more than a dozen Ebola deaths.
At last count on Friday, the virus had killed at least 1,427 people and sickened 1,188 more -- numbers thought to "vastly underestimate" the outbreak's true toll, according to the World Health Organization, which is expected to release updated case counts soon.
Click here for more headlines from the Ebola outbreak.
The outbreak emerged in March and quickly became the deadliest on record. An estimated 48 percent of all Ebola deaths recorded since the virus's discovery in 1976 have occurred in the last five months, according to WHO data.
Here are 10 things you should know about the outbreak as fears continue to mount in Guinea, Liberia, Sierra Leone, Nigeria and beyond.
Congo Reports First Ebola Cases, Deaths
The Democratic Republic of Congo may be 800 miles from the nearest Ebola cases in Nigeria, but the Congolese government says that it has confirmed two Ebola deaths in the country and suspects that the virus has claimed 13 people in all, according to the Associated Press.
The World Health Organization is expected to release new case counts soon.
Ebola was first discovered in the Congo in 1976 and is named for the Ebola river, according to the WHO.
British Ebola Patient Evacuated From Sierra Leone
The first British Ebola patient, an unnamed health worker in Sierra Leone, will be evacuated from the area for treatment, according to the Associated Press.
The Royal Air Force sent a special jet to collect the patient from the town of Lungi and transport him to London, where he will receive treatment in an isolation unit at the Royal Free Hospital, according to the AP.
The patient is "is not currently seriously unwell," the British Department of Health told the AP.
African Doctor Who Got ZMapp Dies From Ebola
The growing outbreak has left pharmaceutical companies scrambling to test drugs that could treat and prevent the infection.
There is currently no drug approved to fight Ebola, but WHO has allowed medical professionals to use experimental or untested medications in a last-ditch effort to save lives.
One drug, an experimental treatment known as ZMapp, has been used to treat six patients: American health workers Dr. Kent Brantly and Nancy Writebol, a Spanish priest, two African doctors and one African nurse. Brantly and Writebol survived but the Spanish priest and one of the African doctors did not.
Still, experts say it's unclear whether ZMapp -- a cocktail of three antibodies that attack the virus -- actually helped those who received it. Before Brantly received his dose, the drug had only been tested in monkeys.
"Frankly we do not know if it helped them, made any difference, or even delayed their recovery," said Dr. Bruce Ribner, director of Emory University Hospital's infectious disease unit, where Brantly and Writebol were treated.
Experimental Ebola Drug's Role in Americans' Recoveries Remains Unclear
This week, Japan announced that it could provide an anti-influenza drug to 20,000 Ebola patients. The drug has not been tested or approved for the treatment of Ebola, but the Japanese company that developed it said it could work in theory.
Another drug, an Ebola vaccine developed by the U.S. National Institutes for Health, is scheduled to be tested on humans for the first time in September. Another vaccine out of Canada is also expected to be tested, the Associated Press reported.
American Ebola Survivors Leave Hospital
Dr. Kent Brantly, 33, and missionary Nancy Writebol, 59, have been discharged from Emory University Hospital, where they were being treated for Ebola. They contracted the virus while working with aid groups in Liberia.
Brantly left the hospital Thursday, calling it a "miraculous day" as he stood surrounded by the Emory medical staff for a news conference.
"I am thrilled to be alive, to be well, and reunited with my family," he said.
Moments later, he hugged about a dozen Emory health care workers. Though he underwent blood and urine tests to be sure the virus was no longer in his system, the hugs helped ease people's fears about his release, experts said.
Writebol, whose quiet discharge from the hospital happened Tuesday, seemed "strong" and "thankful" when she spoke to her pastor Jim Cashwell in Charlotte, Cashwell told ABC affiliate WSOC.
Why American Ebola Survivor Got So Many Hugs
U.S. Hospitals Taking No Chances
Hospitals and state labs across the country have reported 68 possible Ebola cases to the U.S. Centers for Disease Control and Prevention over the last three weeks. Only 10 of these patients raised CDC's concerns enough to test their blood for the virus, and all of the results have come back negative so far, CDC officials said.
The latest scare involved a patient at Kaiser Permanente South Sacramento Medical Center in California whose negative test results were announced Thursday.
Potential Ebola patients at Mount Sinai Hospital in New York, Johns Hopkins Medicine in Maryland, University of New Mexico Hospital in Albuquerque and an undisclosed hospital in Ohio have also tested negative for Ebola over the past several weeks.
The CDC had sent a health alert to hospitals across the country urging them to ask patients about their travel history to help identify potential Ebola cases.
Officials Warn of 'Shadow Zones,' 'Invisible' Cases
The Ebola outbreak is already the deadliest on record, and WHO officials say the impact may be far worse than reported.
The number of known infections -- currently 2,473 -- is underestimated because of those who hide the infected and bury the dead in secret, WHO said in a statement today. The number also excludes so-called "shadow zones," which are rumored to have Ebola cases that go unconfirmed because of community resistance and a lack of medical staff, the agency said.
Health officials also suspect an "invisible caseload" in Liberia because new treatment facilities are filling with previously unidentified Ebola patients as soon as they open.
Ebola Toll May 'Vastly Underestimate' Crisis
1 in 4 Americans Fears Ebola Outbreak, Poll Shows
About a quarter of Americans fear that they or someone in their family will come down with Ebola in the next year, according to a Harvard School of Public Health poll released today.
Harvard and SSRS, an independent research company, conducted the poll of 1,025 adults last week and found that 39 percent of respondents feared a large Ebola outbreak in the United States.
According to the poll, 68 percent of Americans thought the disease could spread "easily" and 33 percent said they thought there was an available treatment for it, both highlighting a lack of understanding about Ebola in this country. In reality, the virus is only transmitted through contact with body fluids like blood and urine, and there is no cure. It's unclear whether ZMapp, the unofficial drug given to the American Ebola patients, helped or hindered their recovery, experts say.
New Nigerian Cases Linked to Sick Plane Passenger
Two Nigerians have been diagnosed with Ebola after their spouses helped treat American-Liberian Patrick Sawyer.
Sawyer flew from Liberia to Nigeria with Ebola and was quarantined when the plane landed, but he had already infected 11 people, the Associated Press reported. He died in July.
Of the 13 Nigerian patients, four have died, five have recovered and four are still in isolation, according to the AP.
Officials Request Exit Screenings at Airports, Seaports
The World Health Organization has requested exit screenings at international airports, seaports and land crossings in all countries affected by the Ebola outbreak.
"Any person with an illness consistent with [Ebola virus disease] should not be allowed to travel unless the travel is part of an appropriate medical evacuation," WHO said in a statement. "There should be no international travel of Ebola contacts or cases, unless the travel is part of an appropriate medical evacuation."
Ebola symptoms include fever, weakness, muscle pain and sore throat before they progress to vomiting, diarrhea and rash. Some people may also experience bleeding.
The WHO Ebola Emergency Committee advised against international travel or trade restrictions at this time.
Governments Are Reviving the 'Cordon Sanitaire'
Officials from Guinea, Sierra Leone and Liberia have implemented a "cordon sanitaire" or sanitary barrier -- a cross-border isolation zone designed to contain people with the highest infection risk.
The tactic, used to prevent the spread of plague in medieval times, literally blocks off an area thought to contain 70 percent of the epidemic. But some experts say there's little proof that isolation zones can prevent the spread of disease.
Ebola-Stricken Countries Turning to Ancient Practice to Curb Outbreak
"It may not be sufficiently structured so it can prevent people from leaving," said Dr. William Schaffner, an infectious disease expert at Vanderbilt Medical Center in Nashville, Tennessee.
Fearful Communities Are Shunning Survivors
An estimated 47 percent of people infected in the outbreak have survived the virus, according to WHO. But they face fear and shame from their communities.
Survivor Sulaiman Kemokai, from Sierra Leone, said people in his community are afraid to touch him even though he's been declared virus-free, the Associated Press reported.
Ebola Survivor Shunned by Boyfriend, School
The Ebola virus can only be spread through contact with bodily secretions such as blood, urine or sweat. But misinformation is rampant in areas hardest hit by the virus, health officials said.
FDA Warns Against Fake Ebola Treatments
The U.S. Food and Drug Administration is warning people to avoid fake Ebola treatments and vaccines being sold online. The agency said products claiming to protect people from the infection began popping up online after the outbreak began in March.
"There are currently no FDA-approved vaccines or drugs to prevent or treat Ebola," the agency said in a statement. "Although there are experimental Ebola vaccines and treatments under development, these investigational products are in the early stages of product development, have not yet been fully tested for safety or effectiveness, and the supply is very limited."
"There are no approved vaccines, drugs, or investigational products specifically for Ebola available for purchase on the Internet," the FDA added. "By law, dietary supplements cannot claim to prevent or cure disease."
Congo Reports First Ebola Cases as Outbreak Continues